Expired contract

DHSC:SCI: support for a review of voluntary scheme for branded medicines

Details

Value
GBP 99,600
Duration
3 months
Topic
Project management consultancy services
Published
22 May 2025

Tender description

• The Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) is a rebate scheme on the pharmaceutical industry which generates income for the NHS and controls the bottom line of the NHS budget. This is critical to the financial sustainability of the NHS by controlling how much the NHS spends on branded drugs - this is one of the largest commercial agreements in Government. VPAG also includes important elements that support the wider medicines environment, including supporting greater and timelier patient access to new clinically and cost-effective medicines, and support for innovation.

Timeline

  1. Completed: Award date14 April 2025
  2. Completed: Award published22 May 2025
    Current notice
  3. Completed: Contract expiry date15 July 2025

About the buyer

Department of Health and Social Care is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 72224000 · Project management consultancy services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

35 similar open tenders

See more open tenders related to DHSC:SCI: support for a review of voluntary scheme for branded medicines.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.